Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,354,000 | 5,144,000 | 3,627,000 | 2,388,000 | 1,022,000 |
| Depreciation Amortization | 268,000 | 836,000 | 575,000 | 348,000 | 158,000 |
| Accounts receivable | 81,000 | -1,076,000 | -842,000 | -588,000 | -544,000 |
| Accounts payable and accrued liabilities | 42,000 | 1,503,000 | 1,328,000 | 409,000 | 188,000 |
| Other Working Capital | 45,000 | 993,000 | 861,000 | 357,000 | 159,000 |
| Other Operating Activity | 338,000 | 135,000 | 23,000 | 503,000 | 602,000 |
| Operating Cash Flow | $2,128,000 | $7,535,000 | $5,572,000 | $3,417,000 | $1,585,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -121,000 | -532,000 | -387,000 | -260,000 | -145,000 |
| Net Acquisitions | -28,000 | -12,452,000 | -12,282,000 | -12,282,000 | -736,000 |
| Purchase Of Investment | -1,342,000 | -851,000 | -851,000 | -851,000 | 0 |
| Sale Of Investment | 33,000 | 899,000 | 881,000 | 9,000 | 8,000 |
| Investing Cash Flow | $-1,458,000 | $-12,936,000 | $-12,639,000 | $-13,384,000 | $-873,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -6,000 | -19,000 | 335,000 | -425,000 | 144,000 |
| Debt Issued | N/A | 20,660,000 | 16,660,000 | 16,655,000 | N/A |
| Debt Repayment | 0 | -4,018,000 | -15,000 | -11,000 | N/A |
| Common Stock Issued | 77,000 | 155,000 | 123,000 | 101,000 | 47,000 |
| Common Stock Repurchased | -409,000 | -7,586,000 | -6,342,000 | -5,344,000 | -342,000 |
| Dividend Paid | -924,000 | -3,294,000 | -2,454,000 | -1,604,000 | -786,000 |
| Other Financing Activity | 43,000 | -146,000 | -124,000 | -133,000 | 7,000 |
| Financing Cash Flow | $-1,219,000 | $5,752,000 | $8,183,000 | $9,239,000 | $-930,000 |
| Exchange Rate Effect | -294,000 | -300,000 | -241,000 | -220,000 | -224,000 |
| Beginning Cash Position | 8,399,000 | 8,348,000 | 8,348,000 | 8,348,000 | 8,348,000 |
| End Cash Position | 7,556,000 | 8,399,000 | 9,223,000 | 7,400,000 | 7,906,000 |
| Net Cash Flow | $-843,000 | $51,000 | $875,000 | $-948,000 | $-442,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,128,000 | 7,535,000 | 5,572,000 | 3,417,000 | 1,585,000 |
| Capital Expenditure | -121,000 | -532,000 | -387,000 | -260,000 | -145,000 |
| Free Cash Flow | 2,007,000 | 7,003,000 | 5,185,000 | 3,157,000 | 1,440,000 |